Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome

Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment.

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2016-07, Vol.55 (7), p.1337-1339
Main Authors: Barratt-Due, Andreas, Fløisand, Yngvar, Orrem, Hilde L, Kvam, Ann K, Holme, Pål A, Bergseth, Grethe, Tjønnfjord, Geir E, Mollnes, Tom E
Format: Article
Language:English
Subjects:
APS
CAPS
Catastrophic antiphospholipid syndrome
clinical efficacy
Clinical medical disciplines: 750
Eculizumab
Letters to the Editor
Medical disciplines: 700
pathophysiology
Rheumatology: 759
treatment
VDP
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Catastrophic antiphospholipid syndrome is associated with excessive complement activation explaining the clinical efficacy of complement inhibitory treatment.
ISSN:1462-0324
1462-0332
1462-0332
DOI:10.1093/rheumatology/kew040